Close
Nordic 9Nordic 9

Carbyne Equity Partners (investor - Private Equity)

Germany carbynepartners.de
See something wrong or missing? Let us know
Offices:Hamburg

Carbyne Equity Partners is a private equity firm from Germany that invests in growing European businesses

Average round investment:134.94M USD
Average number per year:2.0
Distribution: 2024 (3)2023 (1)
Portfolio companies: France Elicit PlantGermany Isotopen Technologien MünchenSwitzerland Fotokite
Mostly invests in: Germany Germany (2) Biotech (2)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Carbyne Equity Partners

Name Criteria
United Kingdom Intermediate Capital Group
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services, Manufacturing, Transportation
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Prima Materia
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Pharma, Health services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: Germany, France, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Italy H14
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Pharma, Health services, Competitive Intelligence, Transportation
  • Similar business models: B2B
  • Common investees countries: Germany, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Liechtenstein LGT
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Agriculture, Manufacturing, Competitive Intelligence, Transportation
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany BMW i Ventures
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Competitive Intelligence, Transportation
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Rewe Group
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Agriculture, Manufacturing, Transportation
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Singapore ABC World
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Canada Investissement Québec
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services, Manufacturing, Transportation
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Iconiq Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: Germany, France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom AstraZeneca
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Pharma, Health services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Top